Sciencell

GeneQuery™ Human Thyroid Cancer And Disorders qPCR Array Kit

Product Code:
 
SC-GK014
Product Group:
 
PCR Kits
Supplier:
 
Sciencell
Regulatory Status:
 
RUO
Target Species:
 
Human
1 / 1
❮❯

No additional charges, what you see is what you pay! *

Show prices   How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges to UK mainland customers, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Related Products
  • Show All

Further Information

Description:
ScienCell's GeneQuery™ Human Thyroid Cancer and Disorders qPCR Array Kit (GQH-TCD) is designed to facilitate gene expression profiling of key genes involved in (i) the development of various types of thyroid cancer (papillary, follicular, and Hürthle cells); (ii) cell cycle regulation in the progression of thyroid cancer; and (iii) thyroid disorders, such as autoimmune thyroiditis and Hashimoto's thyroiditis. 88 genes are selected in this kit based on database and literature research. GeneQuery™ qPCR array kits are qPCR ready in a 96-well plate format, with each well containing one primer set that can specifically recognize and efficiently amplify a target gene's cDNA. The carefully designed primers ensure that: (i) the optimal annealing temperature in qPCR analysis is 65°C (with 2 mM Mg^2+ , and no DMSO); (ii) the primer set recognizes all known transcript variants of target gene, unless otherwise indicated; and (iii) only one gene is amplified. Each primer set has been validated by qPCR with melt curve analysis, and gel electrophoresis.
Extra Description:
This kit is designed to facilitate gene expression profiling of key genes involved in (i) the development of various types of thyroid cancer (papillary, follicular, and Hürthle cells); (ii) cell cycle regulation in the progression of thyroid cancer; and (iii) thyroid disorders, such as autoimmune thyroiditis and Hashimoto's thyroiditis.